Genmab A/S (GMAB) NASDAQ

33.72

+0.07(+0.21%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap97.16B
Enterprise Value88.33B
P/E Ratio15.31
PEG Ratio1.49
Price/Sales Ratio5.71
Price/Book Ratio3.89
Enterprise/Revenue5.39
Enterprise/EBITDA13.95

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.37
Operating Margin0.34

Management Effectiveness

Return On Assets0.21
Return On Equity0.25

Income Statement

Revenue21.53B
Revenue/Share370.93
Gross Profit20.54B
EBITDA9.7B
Net Income7.84B
Diluted EPS12.14

Balance Sheet

Total Cash3.41B
Total Cash/Share298.32
Total Debt142M
Total Debt/Equity0.03
Current Ratio6.22
Book Value Per Share545.59

Price History

52-Week Change64.73
52-Week High33.89
52-Week Low17.24
Moving Average 50 Days30.81
Moving Average 200 Days24.82

Statistics

Average Volume2.14M
Shares Outstanding615.99M
% Held by Institutions10

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor5:1
Last Split DateMay 01, 2018